Results
1
High Growth Stocks
1 companies
Kuros Biosciences
Market Cap: CHF 863.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.60
7D
-1.7%
1Y
-17.6%
